Clinical Research Directory

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Sponsor: Target ALS Foundation, Inc.

Summary

The goal of the study is to generate a biorepository of longitudinal biofluids-blood (plasma and serum), cerebral spinal fluid (CSF) and urine linked to genetics and longitudinal clinical information that are made available to the research community. To accomplish these goals, we will enroll 800 Amyotrophic Lateral Sclerosis (ALS) patients and 200 healthy controls from sites globally, over a 5 year time frame. Additionally, speech and motor function and spirometry measures will be collected bi-weekly in a subset of participants. ALS participants will be asked to come to the clinic for 5 study visits approximately every 4 months. Healthy participants will be coming for 2 study visits with a 12-month interval between visits. These samples and clinical information will be stored in a de-identified manner and made available for investigators to use in future research studies.

Official title: Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At - Home Measures

Key Details

Conditions

Locations (12)